Aberrant NFAT-related signalling has been reported in AD, and NFAT1 seems to be selectively activated early in cognitive decline [1], supporting its possible involvement in the pathogenesis of neurodegenerative diseases/dementias. Here, NFATC2 is linked to dementia.